Aladdin-M by Topcon Launches in the US

August 28, 2020: Aladdin-M by Topcon, has been officially launched in the US. The news was announced today.

Aladdin-M combines corneal topography, pupillometry, and optical biometry to enable objective measurement of corneal curvature, pupil dynamics, and axial length metrics.

Topcon notes the versatile, all-in-one Aladdin-M provides the critical tools needed to support myopia management while also incorporating features for keratoconus screening and contact lens fitting. Aladdin-M’s exclusive software enables documentation of axial length measurements to identify risk factors and track changes in Rx and axial length measurements over time to show progression and response to treatment. The instrument is compact, easy to operate, and offers rapid capture to ensure patient satisfaction.

It is estimated that 50% of the world’s population may be myopic by 20501. With the launch of Aladdin-M, Topcon achieves a milestone in supporting the battle against this global myopia epidemic.

“Aladdin-M is ideally suited to help eye care professionals combat the growing crisis of myopia. Its versatility and ease of use allow eye care professionals to easily build a myopia service within their practice, educate patients on the implications of myopia, manage their patients’ conditions, and grow their service offerings,” stated John Trefethen, Global VP of Marketing & Product Design for Topcon Healthcare.

Topcon will debut the Aladdin-M device at the Vision Source Exchange On-Demand meeting, August 27th – 29th.


Reference

Holden, BA, Fricke,TR, Wilson, DA et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016; 123:1036–42. Available from: doi: DOI: 10.1016/j.ophtha.2016.01.006

SourceTopcon

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.